Company Filing History:
Years Active: 2013
Title: The Innovations of Isabel De Fatima Correia Batista
Introduction
Isabel De Fatima Correia Batista is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on recombinant inhibitors. His dedication to research and development has led to the creation of a unique patent that showcases his expertise.
Latest Patents
Isabel holds a patent for a Kunitz-type recombinant inhibitor. This invention, named Amblyomin-X, is derived from a gene cloned from a cDNA library of salivary glands. The inhibitor has a molecular mass of 13,500 Da, highlighting its potential applications in various therapeutic areas. This patent represents a significant advancement in the field of biotechnology.
Career Highlights
Isabel is currently associated with Coinfair - Consórcio de Indústrias Farmacêuticas, where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the scientific community but has also paved the way for new treatments and therapies. His innovative spirit and commitment to excellence are evident in his research endeavors.
Collaborations
Isabel has collaborated with esteemed colleagues such as Durvanei Augusto Maria and Ana Marisa Chudzinski-Tavassi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Isabel De Fatima Correia Batista is a remarkable inventor whose work in the field of pharmaceuticals has led to significant advancements. His patent for the Kunitz-type recombinant inhibitor exemplifies his innovative approach to solving complex problems in biotechnology. Through his career and collaborations, he continues to inspire future generations of inventors and researchers.